Hybrid Capture NGS‐based assays combined with data analysis solutions for molecular tumor diagnostics and clinical research.


NEOs expertise lies in the development and optimization of Hybrid Capture NGS‐based solutions to support timely results in cancer diagnostics and clinical research.



NEO New Oncology offers reliable support to accommodate your needs - from implementing the technology and providing tailor-made trainings to supporting the evaluation of technically complex analyses.

*NEOplus v2 RUO. For research use only. Not for use in diagnostic procedures.


Molecular cancer profiling platform for research and diagnostics


We are your partner for integrating molecular tumor profiling in precision medicine and research

Job offers

Join the international NEO team

To top